Clinical Trials Directory

Trials / Conditions / Meningococcal Vaccines

Meningococcal Vaccines

13 registered clinical trials studyying Meningococcal Vaccines — 5 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingPhase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 2-6 Years
NCT07505888
Sinovac Biotech Co., LtdPhase 3
Not Yet RecruitingPhase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 12-23 Months
NCT07505836
Sinovac Biotech Co., LtdPhase 3
Not Yet RecruitingPhase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 3-5 Months
NCT07505810
Sinovac Biotech Co., LtdPhase 3
Not Yet RecruitingPhase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 6-11 Months
NCT07505823
Sinovac Biotech Co., LtdPhase 3
CompletedA Study to Learn About How Trumenba Vaccine Shots Work Against Gonorrhea Infection in Teenagers and Young Adul
NCT05873751
Pfizer—
CompletedStudy of Meninigococcal Conjugate Vaccine Containing Serogroups A,C,Y,W and X (MCV5) in Healthy Adults
NCT02810340
PATHPhase 1
CompletedInvestigating Meningococcal Vaccines in Adults
NCT02398396
University of OxfordN/A
CompletedA Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and Bivalent rLP2086 Vacc
NCT01461993
PfizerPhase 2
CompletedA Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Va
NCT01461980
PfizerPhase 2
CompletedPersistence and Booster Study of GSK Biologicals' Meningococcal Vaccine (GSK134612) in Healthy Children
NCT01266993
GlaxoSmithKlinePhase 3
CompletedImmunogenicity and Safety of Meningococcal Vaccine GSK 134612 Co-administered With Pneumococcal and DTPa-HBV-I
NCT01144663
GlaxoSmithKlinePhase 3
CompletedNon-Inferiority of Meningococcal Vaccine GSK134612 Versus Mencevax™ in 2-10 Year Old Subjects
NCT00514904
GlaxoSmithKlinePhase 3
RecruitingNational Bacterial Meningitis Study
NCT04664569
Association Clinique Thérapeutique Infantile du val de Marne—